Näytä suppeat kuvailutiedot

alpha(2B)-adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systems

Courtney MJ; Michel MC; Akerman KEO; Holmberg CI; Kukkonen JP; Bischoff A; Nasman J

dc.contributor.authorCourtney MJ
dc.contributor.authorMichel MC
dc.contributor.authorAkerman KEO
dc.contributor.authorHolmberg CI
dc.contributor.authorKukkonen JP
dc.contributor.authorBischoff A
dc.contributor.authorNasman J
dc.date.accessioned2022-10-28T13:20:46Z
dc.date.available2022-10-28T13:20:46Z
dc.identifier.urihttps://www.utupub.fi/handle/10024/164516
dc.description.abstractThe ability of cloned human alpha(2B)-adrenoceptors heterologously expressed in Sf9 cells and endogenous alpha(2B)-adrenoceptors in NG 108-15 neuroblastoma X glioma cells to couple to increase of intracellular Ca2+ was studied. Ca2+ increases in NG 108-15 cells were detectable but slight, whereas those in alpha(2B)-adrenoceptor-expressing Sf9 cells were greater. In the latter, the maximum Ca2+ increase correlated positively, and the EC50-value of noradrenaline negatively, with the receptor expression density. The order of potency of the agonists was D-medetomidine ([D]-4-[5]-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole) > noradrenaline approximate to clonidine > oxymetazoline, with clonidine and UK14,304 (5-bromo-N-[4,5-dihydro-1H-imidazole-2-yl]-6-quinoxalinamine) being weak partial agonists. In Sf9 cells Ca2+ increases consisted of concomitant mobilization from an intracellular store and influx of extracellular Ca2+. In these cells alpha(2B)-adrenoceptor stimulation also increased the inositol 1,4,5-trisphosphate mass. We conclude that alpha(2B)-adrenoceptors can couple to intracellular Ca2+ increases which may involve prior activation of phospholipase C. (C) 1998 Elsevier Science B.V. All rights reserved.
dc.publisherELSEVIER SCIENCE BV
dc.titlealpha(2B)-adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systems
dc.identifier.urnURN:NBN:fi-fe2021042716377
dc.relation.volume363
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organization-code2609201
dc.converis.publication-id18494725
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/18494725
dc.format.pagerange74
dc.format.pagerange65
dc.identifier.jour-issn0014-2999
dc.okm.affiliatedauthorCourtney, Michael
dc.okm.discipline1182 Biochemistry, cell and molecular biologyen_GB
dc.okm.discipline1182 Biokemia, solu- ja molekyylibiologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeJournal article
dc.relation.doihttps://doi.org/10.1016/S0014-2999(98)00780-8
dc.relation.ispartofjournalEuropean Journal of Pharmacology
dc.relation.issue1
dc.year.issued1998


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot